Whoop faces suit over tech in health tracker watch ...

Oral hearings heard the USPTO side with MSD (Merck) over a term extension for a reissued patent, in a case set to have huge implications for pharma market exclusivity, reports Marisa Woutersen.

29 August 2024 Regeneron accused the Swiss pharma company of infringing a slew of patents related to Eylea and violating the ...

Complex legal battle concerns ‘skinny label’ strategy used by generic drug makers, prompting a $235 million award | Pharma ...

15 February 2024 Judge says UK courts should depart from a European precedent following Brexit | MSD counsel says appeal had ...

Teva insisted panel’s narrow interpretation of ‘claims the drug’ will have a seismic effect on the Orange Book | Stay granted while en banc rehearing is under question | Decision could reshape patent ...

Five-strong team to open new location in the spring | Office will be led by experienced litigators and patent specialists ...

In an exclusive interview, the One IPO Search project lead explains how a change in mindset at the office helped ‘unlock the value’ of UK patent data.

Naoise Gaffney brings robust experience as a patent attorney and professor to the European law firm, and will lead the firm’s UPC practice. Already registered?

‘Distinguished’ litigator Coke Morgan Stewart takes her place as deputy and interim director of the US Patent and Trademark Office, where she was formerly employed for a decade.

Will this year be defined by a concerted shift towards ‘One Health’? Simon Kiddle and Rebecca Tollervey of Mewburn Ellis explore.

To request a FREE 2-week trial subscription, please signup. NOTE - this can take up to 48hrs to be approved.